Ilias Cagiannos Selected Research

Ilias Cagiannos Research Topics

21	Prostatic Neoplasms (Prostate Cancer) 03/2022 - 02/2002
18	Neoplasms (Cancer) 05/2021 - 04/2002
15	Urinary Bladder Neoplasms (Bladder Cancer) 10/2022 - 12/2009
10	Carcinoma (Carcinomatosis) 11/2014 - 04/2012
9	Margins of Excision 10/2017 - 12/2005
6	Venous Thromboembolism 10/2022 - 01/2017
5	Hemorrhage 01/2022 - 07/2014
3	Surgical Wound Infection 01/2020 - 01/2014
2	Infections 12/2021 - 01/2020
2	Hypothermia 05/2021 - 01/2019
2	Lymphatic Metastasis 08/2017 - 11/2003
2	Ischemia 06/2017 - 03/2013
2	Urinary Tract Infections (Urinary Tract Infection) 03/2016 - 01/2014
2	Hypertension (High Blood Pressure) 03/2015 - 07/2008
2	Carcinoma in Situ 10/2014 - 11/2013
2	Extranodal Extension 12/2005 - 02/2004
1	Inflammation (Inflammations) 06/2021
1	Hernia (Hernias) 11/2019
1	Renal Insufficiency (Renal Failure) 11/2019
1	Pathologic Constriction (Stenosis) 11/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2019
1	Kidney Neoplasms (Kidney Cancer) 06/2019
1	Wound Infection (Wound Infections) 03/2016
1	Pulmonary Embolism 07/2014
1	Stroke (Strokes) 07/2014
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2014
1	Myocardial Infarction 07/2014
1	Sepsis (Septicemia) 01/2014
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2014
1	Non-Muscle Invasive Bladder Neoplasms 11/2012
1	Sarcoma (Soft Tissue Sarcoma) 10/2011
1	Hydronephrosis 10/2010
1	Vascular Diseases (Vascular Disease) 07/2008
1	Diabetes Mellitus 07/2008
1	Erectile Dysfunction 01/2008
1	Transitional Cell Carcinoma 11/2007

9	Prostate-Specific Antigen (Semenogelase)IBA 03/2022 - 03/2002
3	AndrogensIBA 12/2021 - 11/2003
2	Lysine (L-Lysine)FDA Link 01/2017 - 07/2014
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	Radium-223IBA 01/2022
1	taxaneIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2021
1	AlbuminsIBA 06/2021
1	Hemoglobins (Hemoglobin)IBA 06/2021
1	Tranexamic Acid (AMCA)FDA Link 05/2018
1	OF 743IBA 08/2014
1	Dihydrotachysterol (AT 10)IBA 08/2014
1	Serum AlbuminIBA 01/2014
1	PlatinumIBA 10/2013
1	Indicators and Reagents (Reagents)IBA 10/2013
1	CreatinineIBA 10/2010
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2008
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2008
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2008
1	nitazoxanide (NTZ)FDA Link 11/2006
1	Hormones (Hormone)IBA 02/2004
1	Tissue Kallikreins (Tissue Kallikrein)IBA 02/2003

19	Prostatectomy (Retropubic Prostatectomy) 08/2021 - 02/2002
17	Cystectomy 01/2022 - 04/2011
9	Nephroureterectomy 11/2014 - 11/2007
8	Therapeutics 01/2022 - 02/2004
8	Nephrectomy 05/2021 - 07/2008
8	Lymph Node Excision (Lymph Node Dissection) 10/2014 - 11/2007
6	Drug Therapy (Chemotherapy) 10/2022 - 10/2011
5	Radiotherapy 10/2018 - 07/2011
5	Adjuvant Chemotherapy 05/2014 - 08/2011
4	Blood Transfusion (Blood Transfusions) 05/2018 - 01/2014
3	Neoadjuvant Therapy 01/2022 - 11/2012
3	Castration 01/2022 - 06/2021
2	Operative Time 12/2019 - 01/2014
2	Urinary Diversion (Ileal Conduit) 11/2019 - 11/2012
1	Esophagectomy 12/2019
1	Renal Replacement Therapy (Therapies, Renal Replacement) 11/2019
1	Length of Stay 11/2019
1	Erythrocyte Transfusion 05/2018
1	Radiofrequency Ablation 10/2013
1	Adjuvant Radiotherapy 01/2013
1	Salvage Therapy 11/2003